89 related articles for article (PubMed ID: 2779525)
1. Determination of the association and dissociation rate constants of muscarinic antagonists on rat pancreas: rank order of potency varies with time.
Waelbroeck M; Camus J; Christophe J
Mol Pharmacol; 1989 Sep; 36(3):405-11. PubMed ID: 2779525
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
[TBL] [Abstract][Full Text] [Related]
5. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
[TBL] [Abstract][Full Text] [Related]
7. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
Waelbroeck M; Tastenoy M; Camus J; Christophe J
Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027
[TBL] [Abstract][Full Text] [Related]
8. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
[TBL] [Abstract][Full Text] [Related]
9. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
10. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
Haddad EB; Mak JC; Barnes PJ
Mol Pharmacol; 1994 May; 45(5):899-907. PubMed ID: 8190106
[TBL] [Abstract][Full Text] [Related]
12. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
Waelbroeck M; Camus J; Winand J; Christophe J
Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
Rinner I; Porta S; Schauenstein K
Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
[TBL] [Abstract][Full Text] [Related]
14. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic antagonists induce different receptor conformations in rat adenohypophysis.
Henis YI; Sokolovsky M
Mol Pharmacol; 1983 Nov; 24(3):357-65. PubMed ID: 6633502
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
17. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
18. Application of competition kinetics to investigate rat brain muscarinic receptors.
Schreiber G; Henis YI; Sokolovsky M
Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
[TBL] [Abstract][Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
Nedoma J; Tucek S; Danilov AF; Shelkovnikov SA
J Pharmacol Exp Ther; 1986 Jan; 236(1):219-23. PubMed ID: 3941394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
